Internal restructuring
Location of affected unit(s)
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.1 - Manufacture of basic pharmaceutical products

200 jobs
Number of planned job losses
Job loss
50 jobs
Number of planned job creations
Job creation
Announcement Date
1 October 2014
Employment effect (start)
1 January 2015
Foreseen end date
31 December 2016


The commercial subsidiary of Sanofi has announced it will cut about 200 positions by 2016 in the framework of a voluntary departure plan (about 10% of the total workforce). The job cuts will mainly affect medical sales representatives. The Works council was informed on 7 October and a negotiation has started just in order to reach an agreement with unions. Management explains there will be no forced dismissals and no forced mobility transfers. About 140 employees could leave the company by age related measures open to those aged 56 or more; they would leave the company and receive allowances approaching last salary level until retirement. Other employees would receive a higher dismissal allowance as incentive to leave the company. According the union CGT, it is the fourth social plan since 2005. At that time, the workforce comprised 5,000 employees. According to AFP press agency, the group Sanofi will create in the same period 50 new positions, so that the net effect of the restructuring will be 150 job losses.


  • 3 October 2014: AFP Liaisons
  • 2 October 2014: L'usine Nouvelle
  • 8 October 2014: AFP Liaisons


Eurofound (2014), Sanofi France, Internal restructuring in France, factsheet number 78037, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/78037.